Vytorin® (ezetimibe/simvastatin) Versus Zocor® (simvastatin) For Patients With High Cholesterol, Data Analysis

... 3 X ULN) in serum transaminases was 1.8 percent overall and 3.6 percent for patients treated with VYTORIN 10/80 mg. These elevations in transaminases were generally asymptomatic, not associated with cholestasis and returned to baseline after discontinuation of therapy or with continued treatment. Doctors should perform blood tests before, and periodically during treatment with VYTORIN when clinically indicated to check for liver problems... click link for more info. ...